Hims & Hers Health Inc.

06/17/2025 | Press release | Distributed by Public on 06/17/2025 18:07

Statement of Changes in Beneficial Ownership (Form 4)

FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Dudum Andrew
2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [HIMS]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Executive Officer
(Last) (First) (Middle)
2269 CHESTNUT STREET, #523
3. Date of Earliest Transaction (Month/Day/Year)
06/13/2025
(Street)
SAN FRANCISCO, CA 94123
4. If Amendment, Date Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 06/13/2025 M 164,368 A (1) 253,679 D
Class A Common Stock 06/13/2025 F 90,672 D $55.48 163,007 D
Class A Common Stock 06/16/2025 S(2) 2,792 D $56.3526(3) 160,215 D
Class A Common Stock 06/16/2025 S(2) 40,120 D $56.4414(4) 245,074 I Held by Trustee of Dudum Family Community Property Trust
Class A Common Stock 06/16/2025 S(2) 7,414 D $56.9019(5) 237,660 I Held by Trustee of Dudum Family Community Property Trust
Class A Common Stock 06/16/2025 M(2) 108,334 A $2.43 268,549 D
Class A Common Stock 06/16/2025 M(2) 17,001 A $2.43 285,550 D
Class A Common Stock 06/16/2025 S(2) 17,001 D $58.6086(6) 268,549 D
Class A Common Stock 06/16/2025 S(2) 90,624 D $56.389(7) 177,925 D
Class A Common Stock 06/16/2025 S(2) 17,710 D $56.9177(8) 160,215 D
Class A Common Stock 06/17/2025 S(2) 15,945 D $58.5033(9) 144,270 D
Class A Common Stock 06/17/2025 S(2) 49,165 D $59.4469(10) 95,105 D
Class A Common Stock 1,194,545 I Held by Trustee of AD 2022 GRAT 3 dated 11-28-2022
Class A Common Stock 1,286,627 I Held by Trustee of AD 2021 GRAT dated 11-1-2021
Class A Common Stock 534,491 I Held by Trustee of AD 2022 GRAT
Class A Common Stock 1,584,506 I Held by Trustee of AD 2023 GRAT dated 9-5-2023
Class A Common Stock 829,185 I Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022
Class A Common Stock 2,874,769 I Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021
Class A Common Stock 990,410(11) I Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
Class A Common Stock 186,723(12) I Held by Trustee of AD 2025 GRAT 3 dated 5-27-2025
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (1) 06/13/2025 M 35,242 (13) (13) Class A Common Stock 35,242 $ 0 105,726 D
Restricted Stock Unit (1) 06/13/2025 M 35,446 (14) (14) Class A Common Stock 35,446 $ 0 248,126 D
Restricted Stock Unit (1) 06/13/2025 M 74,530 (15) (15) Class A Common Stock 74,530 $ 0 819,828 D
Restricted Stock Unit (1) 06/13/2025 M 19,150 (16) (16) Class A Common Stock 19,150 $ 0 287,256 D
Stock Option (right to buy) $2.43 06/16/2025 M(2) 108,334 (17) 06/16/2030 Class A Common Stock 108,334 $ 0 864,731 D
Stock Option (right to buy) $2.43 06/16/2025 M(2) 17,001 (18) 06/16/2030 Class A Common Stock 17,001 $ 0 85,009 D

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Dudum Andrew
2269 CHESTNUT STREET, #523
SAN FRANCISCO, CA 94123
X X Chief Executive Officer

Signatures

/s/ Alexandra Cotter Wilkins, Attorney-in-Fact 06/17/2025
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
(2) The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.
(3) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.20 - $56.495. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
(4) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.83 - $56.815. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
(5) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.82 - $57.05. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
(6) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.79 - $56.68. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
(7) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.79 - $56.78. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
(8) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.79 - $57.26. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
(9) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $58.22 - $58.945. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
(10) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $59.01 - $59.75. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
(11) The balance represents an in-kind transfer of 186,723 Class A Common Shares to the AD 2025 GRAT dated 5-27-2025.
(12) The balance represents an in-kind transfer of 186,723 Class A Common Shares from the Andrew Dudum 2015 Trust dated July 2, 2015.
(13) The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.
(14) The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.
(15) The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.
(16) The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.
(17) The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.
(18) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Hims & Hers Health Inc. published this content on June 17, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on June 18, 2025 at 00:07 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io